Log In
Print this Print this

Teiroc, alendronate

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionInjectable alendronate sodium hydrate
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypercalcemia
Indication DetailsTreat hypercalcemia associated with malignant tumor
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today